Facebook Twitter Instagram You Tube Pinterest LinkedIn RSS Podcasts Video Library Blog
 - Northwestern Memorial Hospital - Chicago

Long-Term Follow-up of Subjects in a Phase 2 or 3 Clinical Trial in which SCH 503034 was Administered for the Treatment of Chronic Hepatitis C (P05063)

Long-Term Follow-up of Subjects in a Phase 2 or 3 Clinical Trial in which SCH 503034 was Administered for the Treatment of Chronic Hepatitis C (P05063)

The primary purpose of this study is to monitor for possible mutation variants in the body in patients previously treated with SCH 503034, a protease inhibitor.

Sponsor:

Schering Plough Research Institute

Principle Investigator:

Steve Flamm, MD

Cost:

None

Contact:

Kim Sipich
312-503-0121

Last UpdateMarch 25, 2011
top